猴痘檢測市場 - 按技術（聚合酶鍊式反應、側流分析）、模式（實驗室檢測、照護端檢測）、最終用途（醫院和診所、診斷實驗室） - 全球預測（2024 - 2032）

Monkeypox Testing Market - By Technology (Polymerase Chain Reaction, Lateral Flow Assay), Mode (Laboratory Testing, Point of Care Testing), End-use (Hospitals and Clinics, Diagnostic Laboratories) - Global Forecast (2024 - 2032)

出版日期: 2024年05月24日 | 出版商:

Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於猴痘爆發發生率不斷增加，猴痘檢測市場在 2024 年和 2032 年期間將錄得 4.5% 的複合年成長率。 2024 年 5 月，世衛組織報告了 26 個國家新增 646 例實驗室確診猴痘病例，其中 15 例死亡。最近，多個地區猴痘病例再次出現，包括以前被認為是低風險的地區。這凸顯了迫切需要有效、及時的診斷解決方案來管理和控制疫情，從而增加了對檢測試劑盒的需求。

各國政府、醫療保健組織和公共衛生當局正在優先考慮制定和實施管理和控制包括猴痘在內的傳染病的綜合策略。這種高度關注是由於對有效監測和回應機制的日益成長的需求所推動的。對醫療保健基礎設施的投資、增強的診斷能力以及建立健全的疾病管理協議都有助於產業的成長。

猴痘檢測產業根據技術、模式、最終用途和地區進行分類。

聚合酶鍊式反應領域將在 2032 年獲得關注，因為 PCR 是一種高度靈敏且特異的方法，用於檢測猴痘病毒的遺傳物質，從而實現早期、準確的診斷。此技術能夠擴增微量病毒 DNA，使其成為診斷猴痘感染不可或缺的工具。基於 PCR 的檢測因其高精度和可靠性而受到青睞，這對於有效的疾病管理和控制至關重要。

診斷實驗室市場佔有率將在 2024 年和 2032 年期間穩步成長，因為這些實驗室負責進行猴痘測試並向醫療保健提供者提供準確的結果。越來越多配備先進檢測技術的診斷實驗室正在推動對猴痘檢測解決方案的需求。此外，醫療設施的擴張和對傳染病管理的日益關注也導致對猴痘檢測服務的需求增加。

由於人們對先進診斷技術的認知和實施不斷提高，到 2032 年，亞太地區猴痘檢測產業將快速擴張。該地區國家正在加強醫療基礎設施，並投資最先進的檢測設施，以對抗傳染病。人們對猴痘的認知不斷提高，需要及早發現以正確治療疾病。此外，地方政府和衛生組織正在優先考慮疾病監測和疫情管理，進一步增加了對猴痘檢測解決方案的需求。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Abbott Laboratories
Aegis Sciences Corporation
Applied DNA Sciences, Inc.
Becton, Dickinson and Company
BioGX
bioMerieux SA
Bio-Rad Laboratories, Inc.
CerTest Biotec
Creative Biogene
Danaher Corporation
Flow Health
Laboratory Corporation of America Holdings
Mayo Clinic Laboratories
Quest Diagnostics, Inc.
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9634

The Monkeypox Testing Market will record 4.5% CAGR during 2024 and 2032, driven by the increasing incidences of monkeypox outbreaks. In May 2024, WHO reported 646 new laboratory-confirmed cases of monkeypox and 15 deaths across 26 countries. Lately, there has been a resurgence of monkeypox cases in various regions, including areas previously considered low risk. This has underscored the urgent need for effective and timely diagnostic solutions to manage and control outbreaks, boosting the demand for testing kits.

Governments, healthcare organizations, and public health authorities are prioritizing the development and implementation of comprehensive strategies to manage and control infectious diseases, including monkeypox. This heightened focus is driven by the growing need for effective surveillance and response mechanisms. Investments in healthcare infrastructure, enhanced diagnostic capabilities, and the establishment of robust disease management protocols are all contributing to the industry growth.

The monkeypox testing industry is classified based on technology, mode, end-use, and region.

The Polymerase Chain Reaction segment will gain traction through 2032, as PCR is a highly sensitive and specific method used to detect the genetic material of the monkeypox virus, enabling early and accurate diagnosis. The technology's ability to amplify minute quantities of viral DNA makes it an indispensable tool in diagnosing monkeypox infections. PCR-based tests are preferred for their high accuracy and reliability, which are crucial for effective disease management and control.

Diagnostic laboratories segment share will grow steadily during 2024 and 2032, as these laboratories are responsible for conducting monkeypox tests and providing accurate results to healthcare providers. The increasing number of diagnostic laboratories equipped with advanced testing technologies is driving the demand for monkeypox testing solutions. Additionally, the expansion of medical facilities and the growing focus on infectious disease management are contributing to the rise in demand for monkeypox testing services.

Asia Pacific monkeypox testing industry will expand at a fast pace through 2032, due to the increasing awareness and implementation of advanced diagnostic technologies. Countries in the region are enhancing their healthcare infrastructure and investing in state-of-the-art testing facilities to combat infectious diseases. There is rising awareness about monkeypox and need for early detection for proper management of the disease. Additionally, regional governments and health organizations are prioritizing disease surveillance and outbreak management, further boosting the demand for monkeypox testing solutions.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of monkeypox cases
  - 3.2.1.2 Increasing awareness among the population
  - 3.2.1.3 Advancements in diagnostic research
  - 3.2.1.4 Rising government funding and initiatives
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of testing
  - 3.2.2.2 Stringent regulatory challenges
3.3 Technological landscape
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Polymerase chain reaction (PCR)
5.3 Lateral flow assay (LFA)
5.4 Other technologies

Chapter 6 Market Estimates and Forecast, By Mode, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Laboratory testing
6.3 Point of care testing

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals and clinics
7.3 Diagnostic laboratories
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa